AUTHORS: Emily E. Nuss, MD and Anthony Sciscione, DO
Preterm labor is defined as regular contractions that result in cervical dilation or effacement prior to 37 wk gestation. Preterm birth is one that occurs after 20 wk gestation and before the completion of 37 wk gestational age.
|
The incidence of preterm births in the U.S. increased from 9.5% in 1981 to 12.7% in 2006 before falling gradually to 11.4% by 2013, then to 10% in 2019. The increase since 1981 is attributed to improvements in pregnancy dating by ultrasound, increased use of assisted reproductive technology, and increased preterm induction or preterm operative delivery for maternal or fetal indications. Between 40% and 45% of these births follow spontaneous preterm labor; either the remaining preterm births result from preterm premature rupture of membranes (PPROM), or they occur secondary to intentional delivery for maternal or fetal indications.
Pregnant women at the extremes of reproductive age (<17 yr and >35 yr) are at greatest risk. Black race is one of the most significant risk factors with the rate of preterm birth averaging 13.9% between 2016 and 2018 compared to 8.7% among Asian Americans and 9.6% in white women. The disparity between African-American and other ethnic American races persists after adjusting for income, education, and other medical risk factors.
Risk factors for premature labor include a prior preterm delivery, intrauterine infection, systemic or genital tract infections, periodontal disease, short interpregnancy interval (<6 mo), short cervical length (<25 to 30 mm), low prepregnancy body mass index (BMI) (<19.8 kg/m2), age (<17 yr or >35 yr), a history of elective pregnancy termination, history of prior stillbirth, African-American race, vaginal bleeding, polyhydramnios or oligohydramnios, multiple gestation, structural abnormalities of the uterus, history of cervical cone biopsy or loop electrocautery excision, in vitro fertilization or ovulation induction, tobacco use, heavy alcohol consumption, cocaine use, heroin use, and psychologic or social stress. The strongest historic risk factor for preterm birth is a previous birth between 16 and 36 wk gestation.
Presenting symptoms include increased pelvic pressure, abdominal cramping or contractions, increased vaginal discharge, vaginal bleeding or spotting, or leakage of fluid.
Causes of premature labor are varied and often difficult to determine. Premature labor may be secondary to infection, systemic illness, trauma, anatomic abnormalities (i.e., uterine anomaly), or a combination of factors. It is thought that cervical ripening is the most common first step to premature labor or delivery. Subsequently, decidual-membrane activation occurs followed by contractions (Box 1).
The differential diagnosis for preterm labor should include preterm rupture of membranes, preterm contractions (contractions before 37 wk gestation that do not result in cervical change), and abdominal pain or cramping secondary to other medical conditions. There are many medical conditions that may cause preterm contractions or premature labor. Treating some of these underlying conditions may improve the prognosis for stopping the preterm labor.
The diagnosis of preterm labor is confirmed in the presence of regular contractions with subsequent cervical change. Suspicion for preterm labor may be heightened if FFN is positive.
Patients with premature labor should be delivered promptly when an intraamniotic infection is suspected or when they have advanced cervical dilation >5 cm, a persistently nonreassuring fetal heart rate tracing, or significant vaginal bleeding concerning for placental abruption having maternal or neonatal implications.
BOX 2 Commonly Used Tocolytic Agents
Ritodrine∗ |
From Marx JA et al: Rosens emergency medicine: concepts and clinical practice, ed 7, Philadelphia, 2010, Elsevier.
TABLE E1 Side-Effect Profiles of Tocolytic Agents
Side Effects | |||
---|---|---|---|
Agent or Class | Maternal | Fetal or Neonatal | Contraindications |
β-adrenergic receptor agonists | Tachycardia and hypotension, tremor (39% vs. 4% with placebo), shortness of breath (15% vs. 1% with placebo), chest discomfort (10% vs. 1% with placebo), pulmonary edema (0.3%), hypokalemia (39% vs. 6% with placebo), hyperglycemia (30% vs. 10% with placebo) | Tachycardia | Tachycardia-sensitive maternal cardiac disease, poorly controlled diabetes mellitus |
Magnesium sulfate | Flushing, diaphoresis, nausea, loss of deep-tendon reflexes (at serum levels of 9.6-12 mg/dl), respiratory paralysis (at serum levels of 12-18 mg/dl), cardiac arrest (at serum levels of 24-30 mg/dl); when used with calcium channel blockers, suppression of heart rate, contractility and left ventricular systolic pressure, and neuromuscular blockade | Data conflict with regard to effect on perinatal mortality | Myasthenia gravis |
Calcium channel blockers | Dizziness, flushing, hypotension when used with magnesium sulfate, suppression of heart rate, contractility, and left ventricular systolic pressure and neuromuscular blockade; elevation of hepatic aminotransferase levels, reflexive headache | Hypotension, preload-dependent cardiac lesions (e.g., aortic insufficiency) | |
Cyclo-oxygenase inhibitors | Nausea, esophageal reflux, gastritis, and emesis; platelet dysfunction (rarely of clinical significance in patients without underlying bleeding disorder) | In utero closure of ductus arteriosus (risk associated with use for >48 hr), patent ductus arteriosus in neonate (conflicting data), oligohydramnios (reversible), NEC (conflicting data) | Platelet dysfunction or bleeding disorder, hepatic or renal dysfunction, gastrointestinal or ulcerative disease, asthma (in women with hypersensitivity to aspirin) |
Oxytocin receptor antagonists | Hypersensitivity injection-site reactions | For atosiban, an increased rate of fetal or infant death (may be attributable to the lower gestational age of infants in the atosiban group) | None |
Nitric oxide donors | Dizziness, flushing, hypotension | Hypotension, preload-dependent cardiac lesions (e.g., aortic insufficiency) |
From Gabbe SG et al: Obstetrics: normal and problem pregnancies, ed 7, Philadelphia, 2017, Saunders.